According to Cognitive Market Research, the global epilepsy therapeutic market size is USD 11258.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.
North America held the major market of more than 40% of the global revenue with a market size of USD 4503.2 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 3377.46 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 2589.39 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.
Latin America market of more than 5% of the global revenue with a market size of USD 562.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 225.16 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.
The hospital pharmacies segment held the highest revenue share in the epilepsy therapeutic market in 2024.
